| Title: | Traffic-related air pollution significantly aggravates the detrimental effect of infections on the risk of Alzheimer's disease and other dementias, especially in non-carriers of APOE4 |
| Journal: | Frontiers in Dementia |
| Published: | 12 Jan 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41602222/ |
| DOI: | https://doi.org/10.3389/frdem.2025.1668381 |
| URL: | https://public-pages-files-2025.frontiersin.org/journals/dementia/articles/10.3389/frdem.2025.1668381/pdf |
Publication 18553
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Alzheimer's disease (AD) is a complex neurodegenerative disorder influenced by various factors, including genetic and exposure-related. Certain combinations of these factors may promote AD more substantially than others. APOE4 is the strongest genetic risk factor for AD. Traffic-related air pollution (TRAP) and infections are important exposure-related AD risk factors. Here we investigated how the interplay between a history of infections and chronically high exposure to TRAP (highTRAP) impacts the subsequent risk of AD and other dementias (AD+) in carriers and non-carriers of APOE4 in UK Biobank (UKB) participants aged 60-75 years. HighTRAP was approximated by the proximity (50 meters or less) of a participant's primary residence to a major road. Chi-square, Wilson score interval, Wald interval, Wald risk ratio, Welch tests, and regression were used to examine statistical significance. We found that UKB participants with a history of various infections (by ICD-10 codes), but without highTRAP, had a 54% increase in AD+ risk. HighTRAP alone did not significantly influence AD+ risk. Individuals with both a history of infections and highTRAP had a 164% higher risk of AD+ compared to those without either factor. That risk was much higher (349%) in non-carriers of APOE4 but became non-significant in APOE4 carriers. We conclude that avoiding high exposure to TRAP may significantly reduce the risk of AD in non-carriers of APOE4 with a history of infections but not in carriers. One potential explanation could be that APOE4 is a stronger AD risk factor, whose AD-promoting effects may outweigh those of other risk factors.</p>
9 Authors
- Vladimir A. Popov
- Svetlana Ukraintseva
- Hongzhe Duan
- Arseniy Yashkin
- Julia Kravchenko
- Igor Akushevich
- Heather Whitson
- Konstantin G. Arbeev
- Anatoliy I. Yashin
1 Application
| Application ID | Title |
|---|---|
| 82705 | Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention |
Enabling scientific discoveries that improve human health